2Cook DR, Stiller RL, Weakly J-N, et al. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg,1989, 68:452-456.
3Sasvarese JJ, Ali HH, Basra S.I, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B 1090U).Anesthesiology ,1988, 68:723-732.
4Barabas E, Zsigmond EK, Kirkpatrick AF. The inhibitory effect of esmolol on human plasmacholinesterase. Can Anaesth Soc J, 1986, 33:332-335.
5Kim KS, Kim KH, Shin WJ, et al. Neuromuscular interactions between mivacmium and esmolol in rabbits. Anaesthesia, 1998, 53:141-145.
6Frishman W, Silverman R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications. Am Heart J, 1979, 98: 119-131.
7Sum CR, Yacobi A, Kartzinel R, et al. Kineties of esmolol, an ultrashort-acting beta blocker, and of its major metabolile. Clin Pharmacol Ther, 1983, 34:427-434.
